Asian investment firm PAG plans to acquire a significant minority stake in speciality injectables company RK Pharma Inc. and its subsidiaries, according to people familiar with the deal. Besides secondary shares sales...
Eiko Lifesciences acquires 25.01% stake in Reflux Pharmaceuticals
Eiko LifeSciences Limited (ELL), announced that it has acquired a 25.01 per cent stake in Reflux Pharmaceuticals Private Limited (RPPL), a pharmaceutical company that specialises in manufacturing and exporting active...
Spanish pharmaceutical firm Esteve sells 26% stake to Germany’s Lubea
Spanish pharmaceuticals company Esteve has agreed to sell a 26% stake to German private investment firm Lubea, which will become a strategic partner, the family-owned firm based in Barcelona said in a statement on...
Astellas Pharma buys Iveric Bio for $5.9 billion
Japan’s Astellas Pharma said it agreed to buy U.S. drugmaker Iveric Bio Inc for about $5.9 billion in its biggest acquisition, giving it access to a range of ophthalmology treatments. The deal marks the fifth...
China’s Fosun drops plan to sell stake in Indian drugmaker Gland Pharma – ET Now
China’s Shanghai Fosun Pharmaceutical Group Co Ltd has withdrawn plans to sell stake in Indian drugmaker Gland Pharma Ltd, ET Now tweeted on Wednesday, citing sources. Fosun Pharma holds a 57.86% stake in the...
CCI clears Berhyanda’s acquisition of Suven Pharma
The Competition Commission of India (CCI) has approved Berhyanda Ltd’s acquisition of up to 76.10% in Suven Pharmaceuticals. The acquisition is “by way of a share purchase agreement of December 26, 2022 and pursuant to...
Nirma Group acquires eye drop maker Stericon Pharma
The Nirma Group has acquired Bengaluru-based Stericon Pharma Pvt Ltd, a maker of eye drops and contact lens solutions. The financial details were not disclosed, but a statement on the private equity (PE) firm...
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
Jounce Therapeutics Inc agreed to be acquired by privately held Concentra Biosciences for $96.46 million while spurning a merger deal with British biotech firm Redx Pharma. The new Concentra deal also involves a...
Sun Pharma acquires 60% stake in Vivaldis Health & Foods for ₹143 cr
Drug major Sun Pharmaceutical on Friday announced that it is set to acquire 60 per cent shareholding in Vivaldis Health & Foods for ₹143.30 crore from its existing shareholders, The remaining 40 per cent...
Thermo Fisher, Celltrion vie for Baxter’s biopharma unit -sources
U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea’s Celltrion Inc are among those competing to acquire the biopharma solutions business of medical device maker Baxter International...
Sun Pharma completes acquisition of Concert Pharmaceuticals
Drug major Sun Pharma said it has completed the acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company inked a pact to acquire Concert in a USD 576 million deal. The drug major has...
Biotech firms Redx Pharma and Jounce Therapeutics to merge in $425 mln deal
British biotech firm Redx Pharma plc and U.S.-based Jounce Therapeutics Inc will merge to create a $425 million entity specialised in treating cancer and fibrotic disease. Redx shareholders will receive 0.2105 Jounce...